Skip to main content
. 2015 Aug;36(8):1426–1430. doi: 10.3174/ajnr.A4320

Table 2:

Univariate analysis comparing patients with moderate hypoperfusion (HIR ≤ 0.447) with patients with severe hypoperfusion (HIR > 0.447)a

Low HIR (≤0.447) High HIR (>0.447) P Value
No. 31 31
Age (yr) (mean) (SD) 67.5 (13.2) 75.4 (13.7) .02
Female (%) (No.) 51.6 (16) 45.2 (14) .8
Arterial hypertension (%) (No.) 80.6 (25) 87.1 (27) .73
Diabetes mellitus (%) (No.) 16.1 (5) 25.8 (8) .53
Smoking (%) (No.) 38.7 (12) 9.7 (3) .02
Hypolipoproteinemia (%) (No.) 54.8 (17) 46.4 (15) .9
Atrial fibrillation (%) (No.) 35.5 (11) 45.2 (14) .6
No. of sections with FHV (median) (IQR) 3 (1–7) 7 (4–10) <.01
NIHSS score on admission (median) (IQR) 5 (4–13) 15 (11–18) <.001
Baseline lesion volume (mL) (median) (IQR) 1.5 (0.27–5.8) 6.7 (2.3–28.2) <.01
Infarct growth (median) (IQR) 1.6 (0.2–10.6) 6.2 (1.4–39.0) <.01
Baseline perfusion deficit (mL) (median) (IQR) 41.2 (15.8–101.7) 117.1 (56.0–171.6) <.01
Tmax ≥ 2 sec 75.6 (24.7–179.4) 143.1 (70.5–170.2) .08
Tmax ≥ 8 sec 10.5 (3.7–61.9) 88.2 (43.7–122.6) <.001
Vessel-occlusion size: .47
    Large (%) (No.) 19.4 (6) 9.7 (3)
    Medium (%) (No.) 80.6 (25) 90.3 (28)
    Small (%) (No.) 0 (0) 0 (0)
Recanalization (%) (No.) 70 (21) 58.1 (18) .43
Favorable outcome at 3 months (%) (No.) 75.9 (22) 32.3 (10) <.01
a

A Fisher exact test and Mann-Whitney U test were used for categoric and continuous variables, respectively.